Lidoflazine in the treatment of chronic atrial fibrillation.
D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000209:etiology; D002908:Chronic Disease; D004562:Electrocardiography; D005260:Female; D006333:Heart Failure / Q000150:complications; D006801:Humans; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000150:complications; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D013610:Tachycardia / Q000139:chemically induced; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014992:Xylenes
D000889:Anti-Arrhythmia Agents; D010879:Piperazines; D014665:Vasodilator Agents; D014992:Xylenes